Last checked at 13 Feb 2024 12:06
LONDON MARKET MIDDAY: Stocks fall but pound up before US data
(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,170.00
Bid:
11,500.00
Ask:
12,270.00
Change:
0.00 (0.00%)
Spread:
770.00 (6.696%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
12,170.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.EU accepts Astrazeneca's application for marketing gout treatment
Thu, 22nd Jan 2015 07:59
The European medicine regulator has approved AstraZeneca's application to market its lesinurad 200mg tablets for gout.Lesinurad helps increase uric acid excretion from the body to relieve gout.The European Medicines Agency accepted the FTSE 100 drug developer's marketing authorisation application (MAA) after it completed 12-month pivotal Phase III combination therapy studies.Lesinurad was the clinically most advanced product candidate of Ardea Biosciences, which Astrazeneca acquired for $1bn in 2012.The drug is a selective uric acid reabsorption inhibitor (SURI) developed for the chronic treatment of hyperuricaemia in combination with xanthine oxidase (XO) inhibitors allopurinol or febuxostat in gout patients when additional therapy is warranted.
More News
13 Feb 2024 09:32
LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:
Read more12 Feb 2024 12:04
LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise
(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.
Read more12 Feb 2024 09:41
LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
Read more12 Feb 2024 09:12
Barclays sees "compelling" entry point at AstraZeneca after recent falls
(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.
Read more9 Feb 2024 09:15
LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:
Read more9 Feb 2024 07:51
LONDON BRIEFING: Barclays buys Tesco's retail banking business
(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.
Read more8 Feb 2024 17:00
LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100
(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.
Read more8 Feb 2024 14:42
London close: Stocks slip as US jobless claims fall
(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.
Read more8 Feb 2024 12:08
LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi
(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.
Read more8 Feb 2024 08:59
LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend
(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.
Read more8 Feb 2024 08:44
TOP NEWS: AstraZeneca confident after 2023 profit more than doubles
(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.
Read more8 Feb 2024 07:58
AstraZeneca shares slip as Q4 profits miss forecasts
(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.
Read more8 Feb 2024 07:50
LONDON BRIEFING: Unilever sets new buyback; Astra profit surges
(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.
Read more2 Feb 2024 08:38
AstraZeneca celebrates latest successful trial of acoramidis in Japan
(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.
Read more